VOYAGER THERAPEUTICS INC. - COMMON STOCK

Voyager Therapeutics to Participate in Upcoming Investor Conferences

02 сен 2021 17:08:39 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Participate in Upcoming Investor Conferences

10 авг 2021 16:20:14 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER™ AAV Capsid and Vectorized Antibody Platform Technologies

09 авг 2021 07:00:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Strategic Shift and Leadership Transitions

19 май 2021 16:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics’ Novel Capsids Demonstrate Robust Delivery Across the Blood Brain Barrier, Widespread CNS Transduction in Non-Human Primates

11 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

10 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2021 Annual Meeting

28 апр 2021 08:00:02 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease

26 апр 2021 08:00:01 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

25 фев 2021 16:01:01 Источник Nasdaq GlobeNewswire

Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference

18 фев 2021 16:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

02 фев 2021 16:01:00 Источник Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 янв 2021 16:03:16 Источник Nasdaq GlobeNewswire